CollPlant Biotechnologies (CLGN) Long-Term Investments (2022 - 2025)
CollPlant Biotechnologies (CLGN) posted Long-Term Investments of $76000.0 for Q4 2025, down 35.59% on a QoQ basis from $118000.0 in Q4 2024, and down 35.59% year-over-year from $118000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Long-Term Investments (2022 - 2025) Analysis & Trends
CollPlant Biotechnologies' Long-Term Investments history runs 4 years deep, the most recent figure standing at $76000.0 for Q4 2025.
- Quarterly Long-Term Investments fell 35.59% year-over-year to $76000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $76000.0 (down 35.59% YoY) and the FY2025 annual result came in at $76000.0, down 35.59% from the prior year.
- Long-Term Investments was $76000.0 for Q4 2025 at CollPlant Biotechnologies, down from $118000.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $188000.0 in Q4 2022 and bottomed at $57000.0 in Q4 2023.
- A 4-year average of $109750.0 and a median of $97000.0 in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2023 — Long-Term Investments plunged 69.68% — and 2024, when it soared 107.02%.
- CollPlant Biotechnologies' Long-Term Investments stood at $188000.0 in 2022, then plunged by 69.68% to $57000.0 in 2023, then jumped by 107.02% to $118000.0 in 2024, then tumbled by 35.59% to $76000.0 in 2025.
- Business Quant data shows CLGN's Long-Term Investments at $76000.0 in Q4 2025, $118000.0 in Q4 2024, and $57000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 505,194.89 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 188,000.00 |